Connection
William Janssen to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications William Janssen has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
|
|
Connection Strength |
|
 |
|
 |
|
0.039 |
|
|
|
-
Calizo RC, Bhattacharya S, van Hasselt JGC, Wei C, Wong JS, Wiener RJ, Ge X, Wong NJ, Lee JJ, Cuttitta CM, Jayaraman G, Au VH, Janssen W, Liu T, Li H, Salem F, Jaimes EA, Murphy B, Campbell KN, Azeloglu EU. Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. Nat Commun. 2019 05 03; 10(1):2061.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|